UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine

Expert review of molecular diagnostics, 2018-05, Vol.18 (5), p.411-421

2018

Volltextzugriff (PDF)

Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood

Therapeutic drug monitoring, 2012-04, Vol.34 (2), p.222-226

2012

Volltextzugriff (PDF)

False-Negative Confirmatory Testing in Patients With Cannabinoid-Positive Urine Drug Screens

JAMA pediatrics, 2024-02, Vol.178 (2), p.199

2024

Volltextzugriff (PDF)

Detection of Drug-Exposed Newborns

Therapeutic drug monitoring, 2018-04, Vol.40 (2), p.166-185

2018

Volltextzugriff (PDF)

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-09, Vol.318 (12), p.1115

2017

Volltextzugriff (PDF)

Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing-Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?

Therapeutic drug monitoring, 2020-08, Vol.42 (4), p.559

2020

Volltextzugriff (PDF)

Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization

Obstetrics and gynecology (New York. 1953), 2019-01, Vol.133 (1), p.98-104

2019

Volltextzugriff (PDF)

Does Labetalol Trigger False Positive Drug Testing Results?

Journal of addiction medicine, 2023-05, Vol.17 (3), p.e209-e210

2023

Volltextzugriff (PDF)

Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function

JAMA : the journal of the American Medical Association, 2023-12, Vol.330 (22), p.2191

2023

Volltextzugriff (PDF)

Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing—Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?

Therapeutic drug monitoring, 2020-08, Vol.42 (4), p.559-564

2020

Volltextzugriff (PDF)

FDA's Final Rule on Laboratory-Developed Tests: What Is the Impact on Clinical Pharmacogenomics in the United States?

The journal of applied laboratory medicine, 2024-10

2024

Volltextzugriff (PDF)

Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure

Clinical chemistry (Baltimore, Md.), 2024-07, Vol.70 (7), p.934-947

2024

Volltextzugriff (PDF)

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)

Genetics in medicine, 2022-04, Vol.24 (4), p.759-768

2022

Volltextzugriff (PDF)

Quantification of prenatal marijuana use: evaluation of the correlation between self‐report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals

Addiction (Abingdon, England), 2022-01, Vol.117 (1), p.172-181

2022

Volltextzugriff (PDF)

Impact of the Opioid Epidemic on Drug Testing

Therapeutic drug monitoring, 2021-02, Vol.43 (1), p.14-24

2021

Volltextzugriff (PDF)

Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah

Obstetrics and gynecology (New York. 1953), 2022-08, Vol.140 (2), p.153

2022

Volltextzugriff (PDF)

The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens

The pharmacogenomics journal, 2021-06, Vol.21 (3), p.308-317

2021

Volltextzugriff (PDF)

Concordance of Umbilical Cord Drug Screening in Multiple Births: Experience from a Reference Laboratory and Academic Medical Center

Journal of analytical toxicology, 2022-07, Vol.46 (6), p.611-618

2022

Volltextzugriff (PDF)

Association of Cannabis Use With Nausea and Vomiting of Pregnancy

Obstetrics and gynecology (New York. 1953), 2022-08, Vol.140 (2), p.266

2022

Volltextzugriff (PDF)

Prevalence of Gabapentinoid and Opioid Copositives in a Reference Laboratory Patient Population

The journal of applied laboratory medicine, 2024-07, Vol.9 (4), p.861-863

2024

Volltextzugriff (PDF)

Testing for Toxic Elements: A Focus on Arsenic, Cadmium, Lead, and Mercury

Laboratory medicine, 2011-12, Vol.42 (12), p.735-742

2011

Volltextzugriff (PDF)

Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?

The journal of applied laboratory medicine, 2023-03, Vol.8 (2), p.341-346

2023

Volltextzugriff (PDF)

Direct Measurement of Free Copper in Serum or Plasma Ultrafiltrate

American journal of clinical pathology, 2009-02, Vol.131 (2), p.160-165

2009

Volltextzugriff (PDF)

Patterns of Drugs and Drug Metabolites Observed in Meconium: What Do They Mean?

Therapeutic drug monitoring, 2015-10, Vol.37 (5), p.568-580

2015

Volltextzugriff (PDF)

Drug Detection in Urine for Evaluating Exposure-No Limits

The journal of applied laboratory medicine, 2018-01, Vol.2 (4), p.648-652

McMillin, Gwendolyn A

2018

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

KollektionJournals@Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(104)
Berichte
(1)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine

Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood

False-Negative Confirmatory Testing in Patients With Cannabinoid-Positive Urine Drug Screens

Detection of Drug-Exposed Newborns

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial

Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing-Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?

Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization

Does Labetalol Trigger False Positive Drug Testing Results?

Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function

Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing—Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?

FDA's Final Rule on Laboratory-Developed Tests: What Is the Impact on Clinical Pharmacogenomics in the United States?

Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)

Quantification of prenatal marijuana use: evaluation of the correlation between self‐report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals

Impact of the Opioid Epidemic on Drug Testing

Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah

The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens

Concordance of Umbilical Cord Drug Screening in Multiple Births: Experience from a Reference Laboratory and Academic Medical Center

Association of Cannabis Use With Nausea and Vomiting of Pregnancy

Prevalence of Gabapentinoid and Opioid Copositives in a Reference Laboratory Patient Population

Testing for Toxic Elements: A Focus on Arsenic, Cadmium, Lead, and Mercury

Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?

Direct Measurement of Free Copper in Serum or Plasma Ultrafiltrate

Patterns of Drugs and Drug Metabolites Observed in Meconium: What Do They Mean?

Drug Detection in Urine for Evaluating Exposure-No Limits

Aktive Filter

Suchergebnisse filtern